Discontinuation report PEDIACEL

Last updated on 2024-04-10 History
Report ID 206912
Drug Identification Number 02243167
Brand name PEDIACEL
Common or Proper name Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) FIMBRIAE FILAMENTOUS HAEMAGGLUTININ TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE INACTIVATED POLIOMYELITIS VACCINE TETANUS TOXOID DIPHTHERIA TOXOID PERTUSSIS TOXOID PERTACTIN
Strength(s) 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials
ATC code J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-12-31
Actual discontinuation date
Remaining supply date 2023-11-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Pediacel will be replaced by vero-Pentacel (DIN #02534797). The formulation and manufacturing processes for Pediacel® and vPentacel® vaccines are nearly identical (except for final presentation – to be reconstituted) and the products are fully interchangeable.
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-04-10 French Compare
v3 2024-04-10 English Compare
v2 2023-10-12 French Compare
v1 2023-10-12 English Compare

Showing 1 to 4 of 4